Daniela D Weber

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Tyrosine Kinase

Cancer Stem Cells

Ultra High Performance Liquid Chromatography

Top Venues

Analytical methods : advancing methods and applications

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Tevini, Sepideh Aminzadeh-Gohari, Daniela D Weber, Luca Catalano, Victoria E Stefan, Elisa Redl, Chiara M S Herzog, Roland Lang, Martin Widschwendter, Thomas Klaus Felder, Barbara Kofler
A validated HPLC-MS/MS method for the quantification of systemic mifepristone after subcutaneous application in mice. Analytical methods : advancing methods and applications 16 (31) (2024)
Joana Pereira-Vieira, Daniela D Weber, Sâmia Silva, Catarina Barbosa-Matos, Sara Granja, Rui Manuel Vieira Reis, Odília Queirós, Young H Ko, Barbara Kofler, Margarida Casal, Fátima Baltazar
Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. Pharmaceutics 16 (4) (2024)
Joana Pereira-Vieira, Daniela D Weber, Sâmia Silva, Catarina Barbosa-Matos, Sara Granja, Rui Manuel Vieira Reis, Odília Queirós, Young H Ko, Barbara Kofler, Margarida Casal, Fátima Baltazar
Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia. Pharmaceutics 16 (4) (2024)
Julia Tevini, Sepideh Aminzadeh-Gohari, Daniela D Weber, Luca Catalano, Victoria E Stefan, Elisa Redl, Chiara M S Herzog, Roland Lang, Martin Widschwendter, Thomas Klaus Felder, Barbara Kofler
A validated HPLC-MS/MS method for the quantification of systemic mifepristone after subcutaneous application in mice. Analytical methods : advancing methods and applications (2024)
Luca Catalano, Sepideh Aminzadeh-Gohari, Daniela D Weber, Rodolphe Poupardin, Victoria E Stefan, William J Smiles, Julia Tevini, René Günther Feichtinger, Sophia Derdak, Martin Bilban, Stefan Bareswill, Markus M Heimesaat, Barbara Kofler
Triple Therapy with Metformin, Ketogenic Diet, and Metronomic Cyclophosphamide Reduced Tumor Growth in MYCN-Amplified Neuroblastoma Xenografts. Metabolites 13 (8) (2023)